Texas Retina Associates
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Texas Retina Associates sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Texas Retina Associates: 5 sponsored US clinical trials, 1 recruiting.
Texas Retina Associates sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Uveitis, Intermediate, with 1 trials.
Upper-quartile sponsor footprint
Texas Retina Associates sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
NCT05486468
One Year Trial Evaluating Safety of Ozurdex With Eylea
NCT03984110
Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
NCT01295112
Ranibizumab and Reduced Fluence PDT for AMD
NCT00527475
Prophylactic Anecortave Acetate in Patients With a Retisert Implant
NCT00570479
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Texas Retina Associates pipeline
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Uveitis, Intermediate (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas Retina Associates: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Texas Retina Associates sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Texas Retina Associates page
5 registered trials is a research-attention snapshot, not an endorsement of Texas Retina Associates or any single study.
- 1 of Texas Retina Associates's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Uveitis, Intermediate is the condition Texas Retina Associates studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Uveitis, Intermediate trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas Retina Associates pipeline card: 5 registered trials from official public datasets.Report a data error.